Work

Probiotics in the treatment of recurrent vaginal infections: Mechanisms, formulation approaches, and clinical evidence

Year: 2026
Type: article
Abstract: Recurrent vaginal infections, particularly recurrent vulvovaginal candidiasis (RVVC) and bacterial vaginosis (BV), remain difficult to manage because symptom resolution does not always translate into durable restoration of the vaginal microbial ecosystem. Conventional antifungal and antibacterial agents are important for treating confirmed infections, but recurrence, antimicrobial resistance, biofilm persistence and disruption of beneficial microorganisms limit long-term outcomes. Probiotics, especially selected Lactobacillus strains, have therefore been investigated as adjunctive approaches to support vaginal microbial balance. Their proposed actions include lactic acid production, competitive exclusion of pathogens, secretion of antimicrobial substances and modulation of mucosal immune responses. This review discusses the vaginal microbiota, probiotic selection, mechanisms of action, oral and intravaginal delivery, formulation approaches, combination strategies, clinical evidence, safety and quality requirements. Particular attention is given to mucoadhesive gels and bio-gels as potential localized delivery systems. Available evidence is promising but heterogeneous, and probiotic effects are strain- and formulation-specific. Probiotics should not replace diagnostic evaluation or established antimicrobial treatment when indicated. Well-designed clinical trials and standardized pharmaceutical quality controls are required before their role in recurrent vaginal infections can be defined with greater certainty.
Language: English
Subfield: Microbiology
Open Access status: hybrid
OpenAlex ID: W7225989828
FWCI:
Cites: 33
Cited by:
Related to: 10